Clinical Trial Update: Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sensor-augmented insulin-pump therapy for post-transplant diabetes mellitus has completed enrollment and status is reported as complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-transplant Diabetes Mellitus

Drugs mentioned

• Sensor-Augmented Insulin-Pump Therapy

Snippet

Sponsor: Medical University of Vienna | Conditions: Hyperglycemia | Phase 3 | Status: COMPLETED